"Phase-II trial of 1,2-diaminocyclohexane (4-carboxyphthalato) platinum (II) (DACCP) in non-small cell lung cancer" by Howard I. Scher

Selected Works of Leonard Kalman

Follow Contact

Article

Phase-II trial of 1,2-diaminocyclohexane (4-carboxyphthalato) platinum (II) (DACCP) in non-small cell lung cancer

Cancer Chemotherapy and Pharmacology (1984)

Howard I. Scher, Memorial Sloan Kettering Cancer Center
David Kelsen, Memorial Sloan Kettering Cancer Center
Leonard Kalman, Memorial Sloan Kettering Cancer Center
Larry Jones, Johnson Matthey
Joseph Burchenal, Johnson Matthey
Richard Gralla, Memorial Sloan Kettering Cancer Center

Link

Disciplines

Pharmacology,
Medicine and Health Sciences,
Surgery and
Endocrinology, Diabetes, and Metabolism

Publication Date

February 1, 1984

DOI

10.1007/BF00254599

Citation Information

Howard I. Scher, David Kelsen, Leonard Kalman, Larry Jones, et al.. "Phase-II trial of 1,2-diaminocyclohexane (4-carboxyphthalato) platinum (II) (DACCP) in non-small cell lung cancer" Cancer Chemotherapy and Pharmacology Vol. 12 Iss. 2 (1984) p. 101 - 103
Available at: http://works.bepress.com/leonard-kalman/18/